Intratumoral interleukin-2 immunotherapy: Activation of tumor-infiltrating and splenic lymphocytes in vivo (Q59281557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Intratumoral interleukin-2 immunotherapy: activation of tumor-infiltrating and splenic lymphocytes in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S M Dubinett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

J Tobias

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A J Cochran

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

D R Wen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

W H McBride

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

30 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

156-162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

Transplantability of human lymphoid cell line, lymphoma, and leukemia in splenectomized and/or irradiated nude mice

30 October 2019

cites work

1 reference

12 December 2020

Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer

1 reference

12 December 2020

Characterization of a CD4-positive T-cell line derived from an athymic (nu/nu) mouse

1 reference

12 December 2020

Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.

1 reference

12 December 2020

Treatment of patients with advanced cancer using tumor-infiltrating lymphocytes and interleukin 2

1 reference

12 December 2020

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

12 December 2020

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors

1 reference

12 December 2020

Local and systemic effects during interleukin-2 therapy of mouse mammary tumors

1 reference

12 December 2020

New clinical trials with interleukin-2: rationale for regional administration.

1 reference

12 December 2020

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

1 reference

12 December 2020

Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha

1 reference

12 December 2020

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

12 December 2020

Recruitment of T lymphocytes and induction of tumor necrosis factor in thyroid cancer by a local immunotherapy

1 reference

12 December 2020

Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma

1 reference

12 December 2020

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity

1 reference

12 December 2020

Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth.

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity

1 reference

12 December 2020

Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes

1 reference

12 December 2020

Tumor immunotherapy by local injection of interleukin 2 and non-reactive lymphocytes. Experimental and clinical results

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action

1 reference

12 December 2020

Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy

1 reference

12 December 2020

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity

1 reference

12 December 2020

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

12 December 2020

T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice

1 reference

12 December 2020

Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Adoptive immunotherapy of murine pulmonary metastases with interleukin 2 and interferon-gamma

1 reference

12 December 2020

The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells

1 reference

12 December 2020

Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes.

1 reference

12 December 2020

Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2

1 reference

12 December 2020

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

12 December 2020

Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression

1 reference

12 December 2020

Global or directed exocytosis?

1 reference

12 December 2020

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

12 December 2020

Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo

1 reference

12 December 2020

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

12 December 2020

Cardiovascular consequences of recombinant DNA technology: interleukin-2.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01741086

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8382559%20AND%20SRC:MED&resulttype=core&format=json